GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
A shift to the later stages of gold and silver bull markets
October 27, 2025 / www.canadianminingreport.com
Gold stocks plunge on metal drop
October 27, 2025 / www.canadianminingreport.com
Gold stocks still up after pullback late in the week
October 20, 2025 / www.canadianminingreport.com
US regional bank slump goes global, driving market into gold
October 20, 2025 / www.canadianminingreport.com
Gold stocks weaker but outperform slump in other sectors
October 13, 2025 / www.canadianminingreport.com